Timothy Triche - Linear Technology Insider

Linear Technology Corporation -- Germany Stock  

EUR 60.61  0.002  0.0033%

Independent Director

Dr. Timothy J. Triche, M.D., is Independent Director of LTC Properties. He was the Director of the Center for Personalized Medicine at Childrens Hospital Los Angeles since July 2010 and previously served as the Chairman of the Department of Pathology and Laboratory Medicine at Childrens Hospital Los Angeles since 1988. He has also been a Professor of Pathology and Pediatrics at the University of Southern California Keck School of Medicine in Los Angeles, California since 1988. He also serves on the Board of Directors of Novelix Pharmaceuticals, Inc., a private biotechnology company, NanoValent Pharmaceuticals, Inc., a private nanotechnology company, GenomeDx, a private biotechnology company, Lifecode, Inc., a private biotechnology company, and Sanguine BioSciences, a private biomedical research company
Age: 71  Director Since 2000      
Triche?s prior service as an independent director of LTC, current and past executive and director experience with other health care companies, and his overall background in the health care industry led the Board to conclude he should be nominated to serve another term as director.

Management Efficiency

Similar Executives

Entity Summary

Linear Technology Corporation (LTC) is traded on Frankfurt Stock Exchange in Germany. and employs 12 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Linear Technology Corporation to your portfolio

Top Management

Linear Technology Leadership Team
Clint Malin, President
Mandi Hogan, President
Peter Lyew, President
Doug Korey, President
James Pieczynski, Director
Pamela ShelleyKessler, President
Caroline Chikhale, President
Wendy Simpson, CEO
Devra Shapiro, Director, CPA
Brent Chappell, President
Timothy Triche, Director
Boyd Hendrickson, Director

Stock Performance

Linear Technology Performance Indicators